Posts by Tang Liu, MD, PhD
-
Targeting CD44 With CRISPR Gene Editing May Improve Prognosis of Osteosarcoma
Using CRISPR gene editing, researchers at Massachusetts General Hospital and China have become the first to identify an association between high CD44 expression and drug resistance in osteosarcoma—and to show that CRISPR can significantly suppress CD44.
Orthopaedic Care at Mass General
At Mass General, our world-class physicians and surgeons treat the full spectrum of musculoskeletal conditions throughout the body, from sprains and strains on the athletic field to carpal tunnel syndrome. Our team offers innovative, research-based treatments that range from limb-saving oncological procedures to complex spinal reconstruction.